A61K 51/0487
Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl
Official title: {Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl anions}
A61K51/0487 (Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl) appears on 18 US grants and 18 published applications in this corpus.
Search patents in A61K- Granted patents
- 18
- Published applications
- 18
- Assignees
- 20
- Inventors
- 53
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- PSMA-targeted radiopharmaceutical for diagnosing and treating prostate cancer19 Mar 2024US 11,931,431 B2Futurechem Co., Ltd.
- Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging26 Dec 2017US 9,850,183 B2Reiley Pharmaceuticals, Inc.
- Metallocene compounds and labeled molecules comprising the same for in vivo imaging26 Jul 2016US 9,399,077 B2Aptenia S.R.L.
- Ghrelin analogues7 Jan 2014US 8,623,326 B2The University of Western Ontario
- Tumor imaging compounds2 Aug 2011US 7,989,649 B2Emory University
- Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging13 Jun 2024US 2024/0190790 A1Reiley Pharmaceuticals, Inc.
- Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging20 Jan 2022US 2022/0017432 A1Reiley Pharmaceuticals, Inc.
- Psma-targeted radiopharmaceutical for diagnosing and treating prostate cancer15 Apr 2021US 2021/0106701 A1Samsung Electronics Co., Ltd.
- Method for treating cancer based on metallofullerene monocrystalline nanoparticles that specifically disrupt tumor blood vessels6 Aug 2020US 2020/0246458 A1Beijing Fullcan Bio-technology Co., Ltd.
- In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics)5 Dec 2019US 2019/0367537 A1Helmholtz-Zentrum Dresden-Rossendorf E. V.
Most cited
By later US patents
- Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound41US 5,167,948 AMallinckrodt Medical, Inc. · 1992
- Amino acid analogs for tumor imaging28US 5,808,146 AEmory University · 1998
- Amino acid analogs for tumor imaging23US 5,817,776 AEmory University · 1998
- Radioactive metals complexed with phosphonate derivatives of dicyclopentadienebis(methylamine)21US 4,515,767 AThe Dow Chemical Company · 1985
- Metallocenes and metallocene derivatives having a radioactive central atom3US 4,028,389 ASchering Corporation · 1977